U.S. Clinical Trial: National Cancer Institute (NCI) Listed a New Clinical Trial for Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

Media coverage

• Title	U.S. Clinical Trial: National Cancer Institute (NCI) Listed a New Clinical Trial for Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	18/11/23
  Persons	Roisin Connolly